Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,548.00p
   
  • Change Today:
      44.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 2,234.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 36,261
  • Market Cap: £1,675.82m
  • RiskGrade: 128
Select chart: 1 week
 

Current

1 week

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-22 575.41 71.79 83.52p 30.0 n/a -17% 32.45p 1.3%
30-Jun-23 621.92 80.64 92.94p 26.9 2.4 +11% 36.03p 1.4%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
30-Jun-2022 575 575 n/a n/a n/a n/a
30-Jun-2023 622 621 n/a n/a n/a n/a
 
Earnings
30-Jun-2022 83.52p 83.52p n/a n/a n/a n/a
30-Jun-2023 92.94p 93.55p n/a n/a n/a n/a
 
Dividend
30-Jun-2022 32.45p 32.45p n/a n/a n/a n/a
30-Jun-2023 36.03p 35.23p n/a n/a n/a n/a
 
Recommendations
Strong Buy 4 4 0 0 0 0
Buy 0 0 0 0 0 0
Neutral 1 1 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 5 5 0 0 0 0
 
Average Rec 9.00 9.00 n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 2,548.00p
Change Today 44.00p
% Change 1.76 %
52 Week High 6,070.00
52 Week Low 2,234.00
Volume 36,261
Shares Issued 65.77m
Market Cap £1,675.82m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.65% below the market average94.65% below the market average94.65% below the market average94.65% below the market average94.65% below the market average
92.73% below the sector average92.73% below the sector average92.73% below the sector average92.73% below the sector average92.73% below the sector average
Price Trend
81.82% below the market average81.82% below the market average81.82% below the market average81.82% below the market average81.82% below the market average
26.98% below the sector average26.98% below the sector average26.98% below the sector average26.98% below the sector average26.98% below the sector average
Income
84.39% below the market average84.39% below the market average84.39% below the market average84.39% below the market average84.39% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
49.64% above the market average49.64% above the market average49.64% above the market average49.64% above the market average49.64% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Mar-22 18-Nov-21
Paid 31-Mar-22 10-Dec-21
Amount 10.30p 21.70p

Trades for 27-Jun-2022

Time Volume / Share Price
15:55 273 @ 2,548.00p
15:55 11 @ 2,548.00p
15:55 14 @ 2,548.00p
15:55 38 @ 2,550.00p
15:55 37 @ 2,550.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page